Signal Notes

Editorial signal briefings on Korean equities, sector momentum, and machine-tracked follow-through.

signal EN Uncategorized 2026-09-29

ClearOne (CLRO) Volume Spikes 19.7x With No Clear Catalyst in Sight

CLRO's volume surged 19.7x its average with no clear catalyst, while a -35.92x price-to-book ratio and widening credit spreads flag real risks to watch.

Chain signal:CLRO:2026-09-28
자동 생성 콘텐츠 자동 분석으로 생성됐으며 모든 문장을 사람이 사전 검수한 것은 아닙니다.

ClearOne (CLRO) Volume Spikes 19.7x With No Clear Catalyst in Sight

Shares of ClearOne (CLRO) drew attention this week as trading volume surged to 19.7x its 20-day average, a sharp spike that arrived without any specific earnings release, regulatory filing, or news catalyst showing up in the public record. With the stock trading around a signal price of $5.10 against a deeply negative price-to-book ratio of -35.92x, the setup reads as a volume-driven watchlist candidate whose validity depends less on a confirmed fundamental narrative than on whether the newly established trading interest around the $4.91 support level can hold.

A quality score of 0.73 and a price score of 0.67 (both on a 0-1 scale) suggest the underlying setup is not without merit, but the absence of a clear catalyst behind the volume spike means the move is best treated as a technical development to monitor rather than a fundamentally confirmed inflection point.

CLRO price chart

Key Facts

Stock nameCLRO
TickerCLRO
MarketNASDAQ
SectorUnclassified
Volume (x average)19.7x
Signal price$5.10

ClearOne, Inc., incorporated in 1983 and headquartered in Salt Lake City, Utah, does not currently have significant operations. The company was previously engaged in the design, development, and marketing of professional audio conferencing, microphone, and video collaboration solutions.

Recent Analyst Coverage

External analyst opinions (not investment advice): (2021-12-01)

Strong Buy3
Buy3
Hold1
Sell0
Strong Sell0

Peer Companies

NTIP, FKWL, WYTC, PRKR, ATGN

Risk Factors

The most stock-specific concern is CLRO's -35.92x price-to-book ratio, which reflects negative shareholder equity rather than simple asset undervaluation — a structural balance-sheet issue rather than a bargain. A debt-to-equity ratio of -360% points to the same distortion, and while an ROE of 745.6% looks striking on the surface, in a negative-equity context it is a mathematical artifact rather than evidence of strong profitability. The most recent EPS data on file, an actual result of -$3.30 versus a -$3.825 estimate (a 13.7% surprise) from the quarter ended 2018-06-30, is also dated and should not be read as a current earnings signal.

On the macro side, the 10-year Treasury yield has climbed to 5.24%, up 0.52 percentage points over the past month, while the high-yield credit spread (HY OAS) has widened to 2.93 percentage points on a rising trend — a combination that tends to pressure thinly capitalized, balance-sheet-challenged names like CLRO more than the broader market. The dollar index has also firmed to 101.2, up 1.5% over the past month, adding another layer of tightening financial conditions. VIX at 16.1 remains in a normal range, so this isn't a broad risk-off panic, but the rate and credit backdrop is not particularly supportive for a stock with this profile.

Recent Disclosures

Recent News

Earnings Trend

Fiscal YearRevenueNet Income
2023-$-1M
2024-$-9M
2025-$-26M

Pre-Trade Checklist

Business & competitive edge understood✅ Company profile summarized above
Leading sector⚠️ Not flagged as a leading sector
Good news already priced in?✅ PBR -35.92배 (자산가치 대비 저평가)
Stop-loss / take-profit set✅ Stop-loss -10% / first take-profit +20% set in advance
Exit plan if wrong✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support

Trade Levels

Signal price$5.10
Stop-loss$4.59 (-10% from signal price)
First take-profit$6.12 (+20% from signal price)
Trailing stop10% from peak
InvalidationClose back below key support ($4.91)

With the signal anchored at $5.10, the levels worth tracking are a stop-loss at $4.59 (-10%) and an initial target of $6.12 (+20%), followed by a 10% trailing stop from any subsequent peak; a close back below the $4.91 support level would undercut the thesis behind this volume-driven setup. Given the negative book value and a rate and credit backdrop that isn't particularly forgiving, CLRO looks like a name to watch through that $4.91-$6.12 range rather than one to act on preemptively.